Wright Medical Group Inc (NASDAQ:WMGI) has earned a consensus recommendation of “Hold” from the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $32.13.

A number of equities analysts have recently commented on WMGI shares. Royal Bank of Canada reissued a “buy” rating and set a $30.00 price target on shares of Wright Medical Group in a report on Thursday, November 2nd. Jefferies Group reissued a “buy” rating and set a $33.00 price target on shares of Wright Medical Group in a report on Thursday, October 12th. Barclays lowered their price target on Wright Medical Group from $33.00 to $30.00 and set an “overweight” rating for the company in a report on Thursday, November 2nd. BMO Capital Markets lowered their price target on Wright Medical Group from $34.00 to $31.00 and set an “outperform” rating for the company in a report on Thursday, November 2nd. Finally, Robert W. Baird reissued a “buy” rating and set a $33.00 price target on shares of Wright Medical Group in a report on Friday, October 6th.

Wright Medical Group (NASDAQ WMGI) traded up $0.20 during trading on Thursday, hitting $23.81. The stock had a trading volume of 753,600 shares, compared to its average volume of 1,028,458. The company has a quick ratio of 0.96, a current ratio of 1.31 and a debt-to-equity ratio of 1.52. Wright Medical Group has a 12 month low of $22.14 and a 12 month high of $31.53.

Wright Medical Group (NASDAQ:WMGI) last posted its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, hitting analysts’ consensus estimates of ($0.16). Wright Medical Group had a negative return on equity of 6.27% and a negative net margin of 38.40%. The company had revenue of $170.50 million during the quarter, compared to analysts’ expectations of $173.50 million. During the same quarter in the previous year, the firm earned ($0.19) EPS. Wright Medical Group’s revenue was up 8.4% on a year-over-year basis. research analysts forecast that Wright Medical Group will post -0.27 EPS for the current year.

In other Wright Medical Group news, Director Richard F. Wallman bought 4,000 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The shares were bought at an average price of $24.00 per share, for a total transaction of $96,000.00. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, SVP Gregory Morrison sold 92,140 shares of the company’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $23.70, for a total value of $2,183,718.00. The disclosure for this sale can be found here. In the last three months, insiders sold 92,440 shares of company stock valued at $2,191,500. Insiders own 9.30% of the company’s stock.

Several institutional investors have recently made changes to their positions in the stock. FMR LLC boosted its position in shares of Wright Medical Group by 5.7% during the 2nd quarter. FMR LLC now owns 15,644,806 shares of the medical device company’s stock valued at $430,075,000 after purchasing an additional 845,909 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Wright Medical Group by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 8,232,880 shares of the medical device company’s stock valued at $226,321,000 after purchasing an additional 145,930 shares in the last quarter. Fisher Asset Management LLC boosted its position in shares of Wright Medical Group by 20.9% during the 3rd quarter. Fisher Asset Management LLC now owns 2,890,789 shares of the medical device company’s stock valued at $74,785,000 after purchasing an additional 500,583 shares in the last quarter. Capital Research Global Investors boosted its position in shares of Wright Medical Group by 60.9% during the 2nd quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock valued at $76,285,000 after purchasing an additional 1,050,000 shares in the last quarter. Finally, Palo Alto Investors LLC boosted its position in shares of Wright Medical Group by 1.8% during the 2nd quarter. Palo Alto Investors LLC now owns 2,676,393 shares of the medical device company’s stock valued at $73,574,000 after purchasing an additional 48,200 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: “Wright Medical Group Inc (WMGI) Receives Consensus Rating of “Hold” from Brokerages” was posted by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.americanbankingnews.com/2017/12/14/wright-medical-group-inc-wmgi-receives-consensus-rating-of-hold-from-brokerages.html.

Wright Medical Group Company Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.